Rheumatoid arthritis Trials in Lansing, United States
Conditions / Rheumatoid arthritis / Lansing, United States
Clinical trials for Rheumatoid arthritis investigate a range of treatment strategies and patient populations.
62 total trials for this combination
Showing top 10 of 62 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00476996 | A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) | TERMINATED | PHASE3 |
| NCT00468546 | A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy | COMPLETED | PHASE3 |
| NCT01146652 | Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND) | COMPLETED | PHASE3 |
| NCT02629159 | A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00717236 | Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT01242514 | Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA) | TERMINATED | PHASE3 |
| NCT00106522 | A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy | COMPLETED | PHASE3 |
| NCT01885078 | An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT01331837 | A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors | COMPLETED | PHASE4 |
| NCT00720798 | An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies | COMPLETED | PHASE3 |